Right, let’s slice into Eagle Eye’s FY25 update. On the surface, you’ve got revenue ticking up slightly and EBITDA growing nicely. But as always with these SaaS players, the devil – and the opportunity – is in the ARR details and strategic manoeuvres. Here’s the breakdown.
Financial Resilience Amidst a Strategic Pivot
Eagle Eye navigated FY25 with a focus on fundamentals, delivering results slightly ahead of market whispers. Key numbers:
- Group Revenue: £48.2m (+1% YoY). Modest, but directionally positive.
- Recurring Revenue (The Golden Goose): £40.2m (+11% YoY). This now makes up a healthy 83% of total revenue (up from 76%).
- Adjusted EBITDA: £12.2m (+9% YoY). Margin improved to 25% (from 24%), showcasing solid cost control.
- Net Cash: £12.3m (+18% YoY). A robust position, especially after shelling out £4.7m for the PPS acquisition.
The headline grabber? A newly announced £1m share buyback programme. This isn’t just loose change management found down the back of the sofa; it’s a deliberate signal of confidence in the future cash flow and the current valuation. Boards don’t authorise buybacks if they’re staring into an abyss.
The ARR Elephant in the Room: Neptune & Underlying Strength
Yes, the reported Organic ARR dipped 19% to £32.0m. That stings. But context is king. This was overwhelmingly driven by the pre-announced loss of a significant contract channelled through Neptune Retail Solutions (NRS). Crucially:
- No other Eagle Eye customers are impacted by the NRS exit.
- Costs tied to that lost contract are being actively stripped out.
Peel back the NRS effect, and the picture brightens considerably: Underlying constant currency organic ARR growth was 5%. Even better? Their EagleAI ARR grew 10%, hitting £5.7m in revenue (+30% YoY) and now representing 19% of total ARR. This AI-driven personalisation engine is clearly gaining traction.
Furthermore, the stickiness of their core business is evident: 83% of revenue from the top 10 customers is locked in until at least FY27. That’s serious revenue visibility.
Strategic Shifts: Building for Scale
FY25 wasn’t just about weathering a storm; it was about laying foundations. Key strategic progress:
1. The Big Bet: The Global OEM Deal
This remains potentially transformative. Embedding Eagle Eye’s tech into a “world’s largest enterprise software vendor’s” new cloud loyalty solution is progressing on schedule.
- Product launched at two major vendor events.
- Pilot customers are onboarded.
- A “considerable and growing” enterprise pipeline exists.
- First contracts expected H1 FY26, substantial revenue from FY27.
This is the long game, but the potential customer reach is enormous.
2. Sharpening the Sales Sword
Acknowledging the need for more firepower, they’ve implemented a new three-pronged sales strategy:
- Reorganised Direct Sales: Led by a new US-based Chief Revenue Officer (CRO) – a clear push for Stateside growth.
- OEM Channel: Leveraging that big partnership.
- Partnerships: Expanding reach through allies.
3. Acquisitions & Model Transition
The acquisition of Promotional Payments Solutions (PPS) closed at year-end. It’s earnings accretive, adds new enterprise customers, and bolsters their real-time CPG couponing. Smart bolt-on.
They’re also deliberately shifting away from heavy professional services, moving towards a System Integrator (SI) model. This explains the 27% drop in PS revenue – it’s a strategic retreat for better long-term margins and scalability. Headcount reductions linked to the NRS loss and this model shift are underway.
Outlook: Confidence Tempered with Realism
Management isn’t pretending FY26 will be a walk in the park. The NRS hangover lingers. However, their guidance is pragmatic and points towards recovery:
- FY26: Targeting maintained double-digit Adjusted EBITDA margin. Expecting a “materially improving trajectory” by the *end* of FY26.
- FY27: The target is clearer: 20%+ Adjusted EBITDA margin alongside double-digit revenue growth. This leans heavily on the OEM deal ramping up and their efficiency programmes bearing fruit.
The strong sales pipeline and secured ARR provide the foundation. The cost actions are necessary medicine.
The Takeaway: Pivoting Towards the Next Phase
Eagle Eye’s FY25 was a tale of resilience. They absorbed a significant ARR body blow, managed costs effectively, generated cash, and made strategic progress where it counts – especially on the potentially game-changing OEM deal and their AI growth.
The £1m buyback is a tangible sign the board believes the market isn’t fully valuing the underlying strength and future prospects. The path to FY27 targets involves navigating the NRS transition and successfully leveraging the OEM channel. Execution on the new sales strategy and cost management will be key watchpoints.
CEO Tim Mason’s summary hits the right note: “Eagle Eye will emerge a stronger organisation.” The FY25 results, while mixed, show a company actively reshaping itself for its next growth chapter, not just hunkering down. The proof, as ever, will be in the FY26 delivery.
